Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR T790M
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
EGFR-RAD51 fusion (5)
EGFR-SEPTIN14 fusion (2)
EGFR fusion (1)
EGFR-GRB2 fusion (1)
KIF5B-EGFR fusion (1)
EGFR fusion + RAD51 fusion (0)
EGFR-RAD51 fusion (5)
EGFR-SEPTIN14 fusion (2)
EGFR fusion (1)
EGFR-GRB2 fusion (1)
KIF5B-EGFR fusion (1)
EGFR fusion + RAD51 fusion (0)
›
Related tests:
FoundationOne® CDx (110)
Guardant360® CDx (54)
cobas® EGFR Mutation Test v2 (13)
Target Selector™ EGFR Mutation Assay
therascreen® EGFR Plus RGQ PCR Kit
FoundationOne® CDx (110)
Guardant360® CDx (54)
cobas® EGFR Mutation Test v2 (13)
Target Selector™ EGFR Mutation Assay
therascreen® EGFR Plus RGQ PCR Kit
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
osimertinib
Sensitive: A1 - Approval
osimertinib
Sensitive
:
A1
osimertinib
Sensitive: A1 - Approval
osimertinib
Sensitive
:
A1
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
lazertinib
Sensitive: A1 - Approval
lazertinib
Sensitive
:
A1
lazertinib
Sensitive: A1 - Approval
lazertinib
Sensitive
:
A1
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
aumolertinib
Sensitive: A1 - Approval
aumolertinib
Sensitive
:
A1
aumolertinib
Sensitive: A1 - Approval
aumolertinib
Sensitive
:
A1
EGFR T790M
Lung Non-Squamous Non-Small Cell Cancer
EGFR T790M
Lung Non-Squamous Non-Small Cell Cancer
osimertinib
Sensitive: A2 - Guideline
osimertinib
Sensitive
:
A2
osimertinib
Sensitive: A2 - Guideline
osimertinib
Sensitive
:
A2
EGFR T790M
Lung Adenocarcinoma
EGFR T790M
Lung Adenocarcinoma
erlotinib
Sensitive: B - Late Trials
erlotinib
Sensitive
:
B
erlotinib
Sensitive: B - Late Trials
erlotinib
Sensitive
:
B
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
afatinib
Sensitive: B - Late Trials
afatinib
Sensitive
:
B
afatinib
Sensitive: B - Late Trials
afatinib
Sensitive
:
B
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
erlotinib + ramucirumab
Sensitive: B - Late Trials
erlotinib + ramucirumab
Sensitive
:
B
erlotinib + ramucirumab
Sensitive: B - Late Trials
erlotinib + ramucirumab
Sensitive
:
B
EGFR T790M
Lung Adenocarcinoma
EGFR T790M
Lung Adenocarcinoma
gefitinib
Sensitive: B - Late Trials
gefitinib
Sensitive
:
B
gefitinib
Sensitive: B - Late Trials
gefitinib
Sensitive
:
B
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
bevacizumab
Sensitive: B - Late Trials
bevacizumab
Sensitive
:
B
bevacizumab
Sensitive: B - Late Trials
bevacizumab
Sensitive
:
B
EGFR T790M
Lung Adenocarcinoma
EGFR T790M
Lung Adenocarcinoma
osimertinib
Resistant: C1 - Off-label
osimertinib
Resistant
:
C1
osimertinib
Resistant: C1 - Off-label
osimertinib
Resistant
:
C1
EGFR T790M
Lung Cancer
EGFR T790M
Lung Cancer
osimertinib
Sensitive: C1 - Off-label
osimertinib
Sensitive
:
C1
osimertinib
Sensitive: C1 - Off-label
osimertinib
Sensitive
:
C1
EGFR T790M
Small Cell Lung Cancer
EGFR T790M
Small Cell Lung Cancer
osimertinib
Sensitive: C1 - Off-label
osimertinib
Sensitive
:
C1
osimertinib
Sensitive: C1 - Off-label
osimertinib
Sensitive
:
C1
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.